As of 2026-03-21, the Relative Valuation of Ocugen Inc (OCGN) is (5.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.04 USD, the upside of Ocugen Inc based on Relative Valuation is -379.5%.
The range of the Relative Valuation is (5.16) - (6.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 28.2x | 24.3x |
| Forward P/E multiples | 20.7x - 26.9x | 21.8x |
| Fair Price | (5.16) - (6.66) | (5.70) |
| Upside | -353.0% - -426.5% | -379.5% |
| Date | P/E |
| 2026-03-17 | -9.90 |
| 2026-03-16 | -9.42 |
| 2026-03-13 | -10.02 |
| 2026-03-12 | -9.46 |
| 2026-03-11 | -9.30 |
| 2026-03-10 | -7.15 |
| 2026-03-09 | -6.71 |
| 2026-03-06 | -6.51 |
| 2026-03-05 | -7.03 |
| 2026-03-04 | -7.92 |
| 2026-03-03 | -7.52 |
| 2026-03-02 | -7.84 |
| 2026-02-27 | -7.36 |
| 2026-02-26 | -7.56 |
| 2026-02-25 | -7.52 |
| 2026-02-24 | -7.20 |
| 2026-02-23 | -6.63 |
| 2026-02-20 | -6.47 |
| 2026-02-19 | -6.43 |
| 2026-02-18 | -5.98 |
| 2026-02-17 | -5.82 |
| 2026-02-13 | -5.70 |
| 2026-02-12 | -5.70 |
| 2026-02-11 | -5.70 |
| 2026-02-10 | -5.74 |
| 2026-02-09 | -5.58 |
| 2026-02-06 | -5.38 |
| 2026-02-05 | -5.38 |
| 2026-02-04 | -5.70 |
| 2026-02-03 | -6.10 |
| 2026-02-02 | -5.78 |
| 2026-01-30 | -5.86 |
| 2026-01-29 | -6.14 |
| 2026-01-28 | -6.22 |
| 2026-01-27 | -6.43 |
| 2026-01-26 | -6.43 |
| 2026-01-23 | -6.71 |
| 2026-01-22 | -6.67 |
| 2026-01-21 | -6.02 |
| 2026-01-20 | -6.75 |
| 2026-01-16 | -6.83 |
| 2026-01-15 | -6.55 |
| 2026-01-14 | -7.60 |
| 2026-01-13 | -7.72 |
| 2026-01-12 | -7.20 |
| 2026-01-09 | -6.06 |
| 2026-01-08 | -6.02 |
| 2026-01-07 | -6.43 |
| 2026-01-06 | -6.22 |
| 2026-01-05 | -5.86 |